Paper35680595
[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].
Zhang CX and 16 others. Zhonghua Xue Ye Xue Za Zhi, 2022. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. [Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study]. Papers, record 35680595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35680595
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytarabine | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Adolescent | |
| Adult | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Daunorubicin | |
| Female | |
| Homoharringtonine | |
| Humans | |
| Induction Chemotherapy | |
| Male | |
| Middle Aged | |
| Nuclear Proteins | |
| Prognosis | |
| Remission Induction | |
| Retrospective Studies | |
| Young Adult |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2021YFC2500300 | National Key Research and Development Program of China | PubMed | ||
| 2020-I2M-C&T-B-084 | CAMS Innovation Fund for Medical Sciences | PubMed | ||
| 21ZXGWSY00030 | Tianjin Municipal Science and Technology Commission Grant | PubMed |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32258060 | Cardiotoxicity of Anthracyclines. | Front Cardiovasc Med | 2020 | https://conductscience.org/library/papers/32258060 | PubMed |
| 2 | 23664707 | Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial. | Lancet Oncol | 2013 | https://conductscience.org/library/papers/23664707 | PubMed |
| 3 | 32029439 | Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32029439 | PubMed |
| 4 | 23248249 | Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23248249 | PubMed |
| 5 | 23398482 | Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis. | Br J Haematol | 2013 | https://conductscience.org/library/papers/23398482 | PubMed |
| 6 | 14673054 | Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/14673054 | PubMed |
| 7 | 27069254 | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. | Blood | 2016 | https://conductscience.org/library/papers/27069254 | PubMed |
| 8 | 27895058 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. | Blood | 2017 | https://conductscience.org/library/papers/27895058 | PubMed |
| 9 | 28632487 | Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28632487 | PubMed |
| 10 | 29090664 | Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia. | Curr Drug Metab | 2018 | https://conductscience.org/library/papers/29090664 | PubMed |
| 11 | 25458084 | Effectiveness of homoharringtonine (omacetaxine mepesuccinate) for treatment of acute myeloid leukemia: a meta-analysis of Chinese studies. | Clin Lymphoma Myeloma Leuk | 2015 | https://conductscience.org/library/papers/25458084 | PubMed |
| 12 | 2015395 | Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. | Blood | 1991 | https://conductscience.org/library/papers/2015395 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 39765351 | [Clinical characteristics and treatment efficacy of newly diagnosed acute leukemia in the plateau]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | https://conductscience.org/library/papers/39765351 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CR1 | 1378 | PubTator's text mining | https://conductscience.org/library/genes/1378 | NCBI Gene |
| ELN | 2006 | PubTator's text mining | https://conductscience.org/library/genes/2006 | NCBI Gene |
| FLT3 | 2322 | PubTator's text mining | https://conductscience.org/library/genes/2322 | NCBI Gene |
| NPM1 | 4869 | PubTator's text mining | https://conductscience.org/library/genes/4869 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35680595
GET https://conductscience.org/api/papers/v1/35680595/authors